Novo Nordisk says experimental drug amycretin show 13% weight loss in trial
Reuters was first to report on the early trial data for Novo Nordisk’s highly anticipated experimental drug amycretin which showed […] The post Novo Nordisk says experimental drug amycretin show 13% weight loss in trial appeared first on Reuters News Agency.